Why is Brawn Biotech falling/rising?

As of 14-Jul, Brawn Biotech Ltd's stock price is currently at 19.00, reflecting a decrease of 0.17, or 0.89%. The stock has experienced a trend reversal, falling after two consecutive days of gains. It is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, but below its 200-day moving average. Additionally, there has been a significant drop in investor participation, with delivery volume on 11 July falling by 95.32% compared to the 5-day average. The stock's year-to-date performance shows a decline of 10.84%, and over the past year, it has decreased by 15.82%, indicating ongoing challenges despite a positive 1-month return of 11.76%.
In the broader market context, Brawn Biotech's short-term performance has been relatively stable with a 1-week return of 0.00%, while the benchmark Sensex has declined by 1.42% during the same period. This suggests that the stock is performing in line with the sector despite its recent price drop. However, the stock's year-to-date and 1-year returns are significantly lower than the benchmark's positive returns of 5.27% and 2.15%, respectively. This underperformance relative to the market may contribute to negative sentiment among investors, further impacting the stock's price movement.